OCT and OCT-A Afer Diabetic Vitrectomy in PDR
Not yet recruiting
- Conditions
- Proliferative Diabetic Retinopathy
- Registration Number
- NCT05938491
- Lead Sponsor
- Assiut University
- Brief Summary
Detection of any structural or vascular changes at the macula after Pars Plana Vitrectomy ( PPV ) in cases with complicated proliferative diabetic retinopathy ( PDR )
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Cases with complicated PDR as persistant vitreous hemorrhage or tractional retinal detachment involving or threatening the macula underwent PPV with or without ILM peeling
Exclusion Criteria
- eyes with media opacity after PPV not allowing imaging of the macula
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method OCT and OCT angiography to assess the macular thickness , outline and vascularity 3 months after surgery Detection of any structural or vascular changes at the macula after Pars Plana Vitrectomy ( PPV ) in cases with complicated proliferative diabetic retinopathy ( PDR ) .
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What structural and vascular changes occur at the macula after vitrectomy in proliferative diabetic retinopathy patients with internal limiting membrane peeling?
How does OCT angiography compare to traditional imaging methods in assessing post-vitrectomy outcomes in PDR patients?
What are the key molecular mechanisms underlying macular edema resolution after PPV in PDR cases with membrane peeling?
Which biomarkers correlate with visual acuity improvement following diabetic vitrectomy as measured by OCT and OCT-A?
What adverse events are associated with internal limiting membrane peeling during vitrectomy for proliferative diabetic retinopathy?